We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+23.43%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$16.4B
AUM Growth
-$5.58B
Cap. Flow
-$3.87B
Cap. Flow %
-23.65%
Top 10 Hldgs %
18.07%
Holding
3,458
New
283
Increased
974
Reduced
1,077
Closed
907

Top Sells

Rank Stock Value
1
ACN icon
Accenture
ACN
+$114M
2
BMY icon
Bristol-Myers Squibb
BMY
+$109M
3
TT icon
Trane Technologies
TT
+$106M
4
MSFT icon
Microsoft
MSFT
+$104M
5
MA icon
Mastercard
MA
+$104M

Sector Composition

Rank Sector Weight
1 Technology 23.03%
2 Healthcare 13.89%
3 Financials 11.27%
4 Consumer Discretionary 8.92%
5 Industrials 8.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HE icon
1076
Hawaiian Electric Industries
HE
$2.26B
$147K ﹤0.01%
4,079
-60,333
-94% -$2.34M
MOO icon
1077
VanEck Agribusiness ETF
MOO
$992M
$147K ﹤0.01%
2,452
-28
-1% -$1.58K
RCI icon
1078
Rogers Communications
RCI
$18.8B
$147K ﹤0.01%
3,659
+640
+21% +$26.7K
RHI icon
1079
Robert Half
RHI
$4.11B
$147K ﹤0.01%
2,803
-733,275
-100% -$34.8M
TRIP icon
1080
TripAdvisor
TRIP
$1.7B
$146K ﹤0.01%
7,700
MDYG icon
1081
State Street SPDR S&P 400 Mid Cap Growth ETF
MDYG
$2.76B
$145K ﹤0.01%
2,725
UHT
1082
Universal Health Realty Income Trust
UHT
$621M
$145K ﹤0.01%
1,836
+45
+3% +$4.24K
INDY icon
1083
iShares S&P India Nifty 50 Index Fund
INDY
$558M
$144K ﹤0.01%
4,668
-1,481
-24% -$41.8K
STRA icon
1084
Strategic Education
STRA
$1.98B
$144K ﹤0.01%
939
-840
-47% -$131K
GATX icon
1085
GATX Corp
GATX
$6.45B
$143K ﹤0.01%
2,367
+37
+2% +$2.22K
CMC icon
1086
Commercial Metals
CMC
$7.53B
$141K ﹤0.01%
6,952
+952
+16% +$16.3K
SMH icon
1087
VanEck Semiconductor ETF
SMH
$60.8B
$141K ﹤0.01%
1,850
BG icon
1088
Bunge Global
BG
$20.9B
$140K ﹤0.01%
3,418
-130
-4% -$5.04K
UBS icon
1089
UBS Group
UBS
$170B
$140K ﹤0.01%
12,196
-19,077
-61% -$196K
PB icon
1090
Prosperity Bancshares
PB
$8.9B
$139K ﹤0.01%
2,346
-1,112
-32% -$64.2K
CGC
1091
Canopy Growth
CGC
$376M
$136K ﹤0.01%
846
+400
+90% +$64.7K
RELX icon
1092
RELX
RELX
$66.7B
$136K ﹤0.01%
5,786
-82,713
-93% -$1.89M
XMMO icon
1093
Invesco S&P MidCap Momentum ETF
XMMO
$6.9B
$136K ﹤0.01%
2,302
CCL icon
1094
Carnival Corporation Ltd
CCL
$38.1B
$135K ﹤0.01%
8,255
-65,378
-89% -$980K
AVAV icon
1095
AeroVironment
AVAV
$7.19B
$134K ﹤0.01%
1,694
-135
-7% -$8.69K
FCX icon
1096
Freeport-McMoran
FCX
$86.2B
$134K ﹤0.01%
11,707
-1,301
-10% -$11.9K
VIVO
1097
DELISTED
Meridian Bioscience Inc
VIVO
$133K ﹤0.01%
5,719
+5,423
+1,832% +$78.6K
WERN icon
1098
Werner Enterprises
WERN
$2.2B
$132K ﹤0.01%
3,055
-4,520
-60% -$186K
NRC icon
1099
NRC Health Common Stock
NRC
$405M
$131K ﹤0.01%
2,255
+1,520
+207% +$80.3K
TXRH icon
1100
Texas Roadhouse
TXRH
$13.7B
$131K ﹤0.01%
+2,496
New +$122K

Similar funds

Glenmede Trust's Q2 2020 Portfolio in Review

As of Q2 2020, Glenmede Trust held 3,458 positions worth $16.4B, down 25% from $21.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Glenmede Trust withdrew a net $3.87B in Q2 2020, closing 907 positions and reducing 1,077 holdings. Its most notable exit was Raytheon Company, an estimated $66.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Glenmede Trust opened a new position in Carrier Global worth $21.3M.

  • Glenmede Trust's largest Q2 2020 buy was Carrier Global: 960,042 shares worth $21.3M.
  • Glenmede Trust added most to State Street SPDR S&P 500 ETF Trust in Q2 2020, an estimated $97.1M increase.
  • Glenmede Trust's biggest Q2 2020 reduction was Accenture, cutting an estimated $114M.
  • Glenmede Trust fully exited Raytheon Company in Q2 2020, selling an estimated $66.5M.
  • Glenmede Trust's ten largest holdings make up 18% of its $16.4B portfolio in Q2 2020.
  • Glenmede Trust opened 283 new positions and closed 907 in Q2 2020.
  • Glenmede Trust's portfolio value fell 25% quarter-over-quarter to $16.4B.

Based on Glenmede Trust's 13F filing for Q2 2020, filed 14 Aug 2020.